PMID- 19240255 OWN - NLM STAT- MEDLINE DCOM- 20090716 LR - 20220316 IS - 0193-1849 (Print) IS - 1522-1555 (Electronic) IS - 0193-1849 (Linking) VI - 296 IP - 6 DP - 2009 Jun TI - RANTES release by human adipose tissue in vivo and evidence for depot-specific differences. PG - E1262-8 LID - 10.1152/ajpendo.90511.2008 [doi] AB - Obesity is associated with elevated inflammatory signals from various adipose tissue depots. This study aimed to evaluate release of regulated on activation, normal T cell expressed and secreted (RANTES) by human adipose tissue in vivo and ex vivo, in reference to monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) release. Arteriovenous differences of RANTES, MCP-1, and IL-6 were studied in vivo across the abdominal subcutaneous adipose tissue in healthy Caucasian subjects with a wide range of adiposity. Systemic levels and ex vivo RANTES release were studied in abdominal subcutaneous, gastric fat pad, and omental adipose tissue from morbidly obese bariatric surgery patients and in thoracic subcutaneous and epicardial adipose tissue from cardiac surgery patients without coronary artery disease. Arteriovenous studies confirmed in vivo RANTES and IL-6 release in adipose tissue of lean and obese subjects and release of MCP-1 in obesity. However, in vivo release of MCP-1 and RANTES, but not IL-6, was lower than circulating levels. Ex vivo release of RANTES was greater from the gastric fat pad compared with omental (P = 0.01) and subcutaneous (P = 0.001) tissue. Epicardial adipose tissue released less RANTES than thoracic subcutaneous adipose tissue in lean (P = 0.04) but not obese subjects. Indexes of obesity correlated with epicardial RANTES but not with systemic RANTES or its release from other depots. In conclusion, RANTES is released by human subcutaneous adipose tissue in vivo and in varying amounts by other depots ex vivo. While it appears unlikely that the adipose organ contributes significantly to circulating levels, local implications of this chemokine deserve further investigation. FAU - Madani, Rana AU - Madani R AD - Centre for Clinical Pharmacology, Div. of Medicine, University College London, 5 University St., London, UK WC1 6JJ. FAU - Karastergiou, Kalypso AU - Karastergiou K FAU - Ogston, Nicola C AU - Ogston NC FAU - Miheisi, Nazar AU - Miheisi N FAU - Bhome, Rahul AU - Bhome R FAU - Haloob, Nora AU - Haloob N FAU - Tan, Garry D AU - Tan GD FAU - Karpe, Fredrik AU - Karpe F FAU - Malone-Lee, James AU - Malone-Lee J FAU - Hashemi, Majid AU - Hashemi M FAU - Jahangiri, Marjan AU - Jahangiri M FAU - Mohamed-Ali, Vidya AU - Mohamed-Ali V LA - eng GR - 078055/Z/05/Z/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090224 PL - United States TA - Am J Physiol Endocrinol Metab JT - American journal of physiology. Endocrinology and metabolism JID - 100901226 RN - 0 (CCL2 protein, human) RN - 0 (CCL5 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CCL5) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) RN - 0 (RNA, Messenger) SB - IM MH - Adult MH - Arteries/metabolism MH - Body Weight MH - Chemokine CCL2/blood MH - Chemokine CCL5/*blood/genetics MH - Female MH - Humans MH - Interleukin-6/blood MH - Intra-Abdominal Fat/blood supply/immunology/*metabolism MH - Male MH - Middle Aged MH - Obesity, Morbid/*immunology/*metabolism MH - Omentum/blood supply/immunology/metabolism MH - Organ Culture Techniques MH - RNA, Messenger/metabolism MH - Subcutaneous Fat, Abdominal/blood supply/immunology/*metabolism MH - Veins/metabolism PMC - PMC2692396 EDAT- 2009/02/26 09:00 MHDA- 2009/07/17 09:00 PMCR- 2010/06/01 CRDT- 2009/02/26 09:00 PHST- 2009/02/26 09:00 [entrez] PHST- 2009/02/26 09:00 [pubmed] PHST- 2009/07/17 09:00 [medline] PHST- 2010/06/01 00:00 [pmc-release] AID - 90511.2008 [pii] AID - E-90511-2008 [pii] AID - 10.1152/ajpendo.90511.2008 [doi] PST - ppublish SO - Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1262-8. doi: 10.1152/ajpendo.90511.2008. Epub 2009 Feb 24.